← Back to Clinical Trials
Recruiting NCT07453485

NCT07453485 Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07453485
Status Recruiting
Phase
Sponsor University of Brasilia
Condition Achilles Tendinopathy (AT)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-01-06
Primary Completion 2029-08-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Neuromuscular Electrical Stimulation (NMES)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-01-06 with a primary completion date of 2029-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Achilles tendon exhibits high tensile strength and can withstand extremely high loads. However, it is susceptible to injuries such as tendinopathies and ruptures, which are associated with structural alterations and loss of function. Strategies have been investigated to enhance clinical rehabilitation. Nevertheless, the effects of neuromuscular electrical stimulation on pain and functional improvement, as well as the optimal dosing parameters for the rehabilitation of Achilles tendon injuries, remain inconclusive. The aim of this study is to compare the immediate effects of two electrical stimulation protocols on pain, functional performance, peripheral oxygen extraction, and maximal tendon displacement during a single leg heel rise functional task in patients with Achilles tendinopathy and/or a history of Achilles tendon rupture. In addition, this study aims to characterize Achilles tendon structural properties and ankle plantarflexor muscle strength in this population.

Eligibility Criteria

Inclusion Criteria: * Primary complaint of pain localized in the midportion (2-6 cm proximal to the calcaneus) or insertion of the Achilles tendon, and/or a history of Achilles tendon rupture occurring at least 3 months prior to assessment. * Pain on palpation of the Achilles tendon. * Pain during load-bearing activities Exclusion Criteria: * Exclusive diagnosis of bursitis confirmed by ultrasonographic assessment * Any other lower limb injury * History of lower limb surgery within the past year * Previous Achilles tendon tenoplasty performed less than 3 months prior to assessment

Contact & Investigator

Central Contact

João LQ Durigan, PhD

✉ joaodurigan@gmail.com

📞 +55 61 3107-8450

Frequently Asked Questions

Who can join the NCT07453485 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Achilles Tendinopathy (AT). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07453485 currently recruiting?

Yes, NCT07453485 is actively recruiting participants. Contact the research team at joaodurigan@gmail.com for enrollment information.

Where is the NCT07453485 trial being conducted?

This trial is being conducted at Brasília, Brazil.

Who is sponsoring the NCT07453485 clinical trial?

NCT07453485 is sponsored by University of Brasilia. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology